How can we assess the risk for sudden cardiac death to decide for primary prophylactic implantable cardioverter-defibrillator in patients with heart failure in 2022?

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jens Cosedis Nielsen, Nikolaos Dagres

Journal title: EP Europace

Journal number: Volume 24, Issue 8, August 2022

Journal publisher: Oxford University Press

Published year: 2022

Published pages: 1199-1200

DOI identifier: 10.1093/europace/euac061

ISSN: 1099-5129